Cargando…
Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold
BACKGROUND: The common cold, the most prevalent contagious viral disease in humans still lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against respiratory viruses in-vitro and has an excellent safety profile. This study investigated the efficacy and safety of an...
Autores principales: | Eccles, Ron, Meier, Christiane, Jawad, Martez, Weinmüllner, Regina, Grassauer, Andreas, Prieschl-Grassauer, Eva |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923116/ https://www.ncbi.nlm.nih.gov/pubmed/20696083 http://dx.doi.org/10.1186/1465-9921-11-108 |
Ejemplares similares
-
Iota-Carrageenan is a potent inhibitor of rhinovirus infection
por: Grassauer, Andreas, et al.
Publicado: (2008) -
Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection
por: Leibbrandt, Andreas, et al.
Publicado: (2010) -
Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis
por: Graf, Christine, et al.
Publicado: (2018) -
Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan
por: Hebar, Alexandra, et al.
Publicado: (2015) -
Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial
por: Ludwig, Martin, et al.
Publicado: (2013)